Starboard plots board coup after buying into Bristol-Myers in lead-up to Celgene buyout vote
Activist investor Jeff Smith inserted himself into the M&A dance between Bristol-Myers Squibb and Celgene at the beginning of this month, when Bloomberg reported …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
